Novus Therapeutics, Inc. 4
4 · Novus Therapeutics, Inc. · Filed May 26, 2017
Insider Transaction Report
Form 4
OCAMPO CHRISTINE
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2017-05-24+52,500→ 52,500 totalExercise: $5.50Exp: 2027-05-23→ Common Stock (52,500 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 52,500 shares of the Issuer's Common Stock. 36,000 shares will vest ratably each month over three years beginning on May 24, 2017 (the "grant date"). 16,500 shares will vest on the later of achievement of a performance-related goal or the first anniversary of the grant date.